-
Mashup Score: 4Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
Abstract. Multiclass high-level transmitted HIV drug resistance is uncommon, and the selection of the optimal initial antiretroviral drug regimen may be challen
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
OFID’s Case of the Month for April discusses an unusual case of multiclass transmitted drug resistance successfully treated with DTG plus tenofovir alafenamide and emtricitabine. 📄:https://t.co/eEc2pU6hKn #OpenForumInfectDis @PaulSaxMD @DrJLi @EllenNagami @KinnaThakarar https://t.co/FL8gXYmpxU
-
-
Mashup Score: 2
We examined contraception use (all hormonal contraception, tubal ligations, and intrauterine device) from 1998 through 2018 at an HIV clinic in Tennessee. Contr
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
Read the study in OFID: https://t.co/t9JXG31XX8 #IDSAJournals #OpenForumInfectDis https://t.co/DkqFni0hQy
-
-
Mashup Score: 0Novel ID Cases and Teaching Cases - 2 year(s) ago
Open Forum Infectious Diseases welcomes both teaching cases demonstrating a key or striking aspect of an ID-related disease and novel case reports describing a
Source: Oxford AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
Enjoying OFID’s Cases of the Month? Looking for teaching cases? Visit OFID’s archive of novel ID cases and teaching cases, updated regularly: https://t.co/Rztp5BzIIz #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi https://t.co/JQmc2tqe8e
-
-
Mashup Score: 5Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet
-
A new study in OFID describes the introduction of an ID inpatient consult rotation elective for early clinical medical students that students, ID fellows and faculty found valuable. 📄:https://t.co/49z0nXkps1 #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @Darcy_ID_doc https://t.co/VieykYZkyg
-
-
Mashup Score: 7Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet
-
A new study in OFID found that prior SARS-CoV-2 infection does not guarantee a high level of antibody-mediated protection against reinfection in the general population. 📄:https://t.co/jzgf5yQelh #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @tmcdade35 https://t.co/1TpqAQOroP
-
-
Mashup Score: 0IDSA Journals Launch Call for Associate Editor Applications - 2 year(s) ago
The Infectious Diseases Society of America’s journals, Clinical Infectious Diseases, The Journal of Infectious Diseases and Open Forum Infectious Diseases, are seeking ID-trained physicians to become associate editors. CID is seeking ID pharmacists (PharmD required) to become associate editors as well. The journals are launching a call for applications for…
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet-
#OpenForumInfectDis is seeking associate editors with expertise in TB/mycobacterial diseases, AMR, clinical microbiology, transplant ID, HIV/SARS-CoV-2/virology and statistics. Learn more and apply: https://t.co/4nHDaJ6mk4 https://t.co/vHPKCPOEcb
-
-
Mashup Score: 10Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet
-
New in OFID: The estimated numbers of children infected with SARS-CoV-2 as of May 2021, based on antibody seroprevalence, were five times higher than reported pediatric cases in 8 states. 📄:https://t.co/DrqZfoChIJ #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi https://t.co/Tt18BMohqG
-
-
Mashup Score: 3Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet
-
OFID: General ID patients reported substantial costs, both financial and social, associated with their visits, and the majority were willing to have a future visit by telemedicine. 📄:https://t.co/dMEqsFMSri #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @JasonPBurnhamMD https://t.co/wxK2id2GCa
-
-
Mashup Score: 2Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19 - 2 year(s) ago
AbstractBackground. Currently, only dexamethasone, tocilizumab and sarilumab have conclusively been shown to reduce mortality of COVID-19. Safe and effective tr
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in OFID: A new analysis estimated and compared the potential generic minimum costs and global availability of a selection of repurposed therapies for COVID-19. 📄: https://t.co/InLcUw3EAI #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi https://t.co/AYi3Kf6nSq
-
OFID: In a low-income cohort in the southeastern U.S., 5% of individuals avoided emergency medical care during the COVID-19 pandemic, primarily due to fear and visitor restrictions. #OpenForumInfectDis 📄:https://t.co/4Zymg76CAv @PaulSaxMD @DrJLi @FungalDoc @DocWoc71 @VUMCepi https://t.co/RqTySBu2p6